BUZZ-U.S. STOCKS ON THE MOVE-Transition Therapeutics, Celator, Meetme

Wed Jun 24, 2015 9:00am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter,; for the Morning News Call newsletter, Wall Street was set to open lower on Wednesday after a setback in Greece's debt talks even as data showed that the U.S. economy's first-quarter contraction was smaller than earlier thought. Dow Jones industrial average futures were down 0.38 percent at 17,999, S&P 500 futures were down 0.24 percent at 2,111.5 and Nasdaq 100 futures were down 0.20 percent at 4,532.25.

** TRANSITION THERAPEUTICS INC, Tuesday close $9.09, -58.64 pct premarket

The drug developer said a mid-stage study of its experimental neuropshychiatric drug, ELND005, did not meet the main goal of significant reduction in agitation and aggression.

** CELATOR PHARMACEUTICALS INC, Tuesday close $2.24, +20.98 pct premarket

The drug developer said its experimental chemotherapy combination, CPX-351, showed relative improvement in response rate in patients with a form of blood cancer in a late-stage study.

** MEETME INC, Tuesday close $1.44, +25.69 pct premarket   Continued...